These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17487834)

  • 1. Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients.
    Maurel J; Nadal C; Garcia-Albeniz X; Gallego R; Carcereny E; Almendro V; Mármol M; Gallardo E; Maria Augé J; Longarón R; Martínez-Fernandez A; Molina R; Castells A; Gascón P
    Int J Cancer; 2007 Sep; 121(5):1066-71. PubMed ID: 17487834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy.
    Szarvas T; Becker M; Vom Dorp F; Meschede J; Scherag A; Bánkfalvi A; Reis H; Schmid KW; Romics I; Rübben H; Ergün S
    Int J Cancer; 2011 Mar; 128(6):1486-92. PubMed ID: 20473942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients.
    Martínez-Fernandez A; García-Albeniz X; Pineda E; Visa L; Gallego R; Codony-Servat J; Augé JM; Longarón R; Gascón P; Lacy A; Castells A; Maurel J
    Ann Surg Oncol; 2009 May; 16(5):1412-20. PubMed ID: 19259740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
    Nikkola J; Vihinen P; Vuoristo MS; Kellokumpu-Lehtinen P; Kähäri VM; Pyrhönen S
    Clin Cancer Res; 2005 Jul; 11(14):5158-66. PubMed ID: 16033831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
    Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
    Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer.
    Gallego R; Codony-Servat J; García-Albéniz X; Carcereny E; Longarón R; Oliveras A; Tosca M; Augé JM; Gascón P; Maurel J
    Endocr Relat Cancer; 2009 Mar; 16(1):311-7. PubMed ID: 19109398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum matrix-metalloproteinase-1 is a bona fide prognostic marker for colorectal cancer.
    Tahara K; Mimori K; Iinuma H; Iwatsuki M; Yokobori T; Ishii H; Anai H; Kitano S; Mori M
    Ann Surg Oncol; 2010 Dec; 17(12):3362-9. PubMed ID: 20617463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological significance and prognostic value of MMP-13 expression in colorectal cancer.
    Yang B; Gao J; Rao Z; Shen Q
    Scand J Clin Lab Invest; 2012 Oct; 72(6):501-5. PubMed ID: 22950625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis.
    Sun DW; Zhang YY; Qi Y; Zhou XT; Lv GY
    Cancer Epidemiol; 2015 Apr; 39(2):135-42. PubMed ID: 25677090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer.
    Zhu X; Han Y; Yuan C; Tu W; Qiu G; Lu S; Lu H; Peng Z; Zhou C
    Oncol Rep; 2015 Jan; 33(1):320-8. PubMed ID: 25338725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between the serum levels of matrix metalloproteinase 9 and colorectal cancer.
    Rašić I; Rašić A; Akšamija G; Radović S; Šehović N
    Med Glas (Zenica); 2017 Aug; 14(2):229-235. PubMed ID: 28644426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of MMP-7 protein and its serum level in colorectal cancer.
    Pryczynicz A; Gryko M; Niewiarowska K; Dymicka-Piekarska V; Ustymowicz M; Hawryluk M; Cepowicz D; Borsuk A; Kemona A; Famulski W; Guzinska-Ustymowicz K
    Folia Histochem Cytobiol; 2013; 51(3):206-12. PubMed ID: 24203626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of plasma ORM2 levels in patients with stage II colorectal cancer.
    Gao F; Zhang X; Whang S; Zheng C
    Ann Clin Lab Sci; 2014; 44(4):388-93. PubMed ID: 25361921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations of serum VEGF and MMP-2 levels with CLM in CRC patients and effects of TACE on their expressions.
    Xu H; Ren YJ; Liu K; Min XL; Yang L; Zhou Y; Zheng J; Yang C
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3394-3401. PubMed ID: 29917190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of serum matrix metalloproteinase-13 levels in patients with esophageal squamous cell carcinoma (ESCC).
    Jiao XL; Chen D; Wang JG; Zhang KJ
    Eur Rev Med Pharmacol Sci; 2014; 18(4):509-15. PubMed ID: 24610617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of matrix metalloproteinases: MMP-2 and MMP-9 predicts poor survival outcome in colorectal carcinoma.
    Salem N; Kamal I; Al-Maghrabi J; Abuzenadah A; Peer-Zada AA; Qari Y; Al-Ahwal M; Al-Qahtani M; Buhmeida A
    Future Oncol; 2016 Feb; 12(3):323-31. PubMed ID: 26814712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of matrix metalloproteinase-1 levels in peripheral plasma and tumour tissues of lung cancer patients.
    Li M; Xiao T; Zhang Y; Feng L; Lin D; Liu Y; Mao Y; Guo S; Han N; Di X; Zhang K; Cheng S; Gao Y
    Lung Cancer; 2010 Sep; 69(3):341-7. PubMed ID: 20060194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
    Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma.
    Wang WS; Chen PM; Wang HS; Liang WY; Su Y
    Carcinogenesis; 2006 May; 27(5):1113-20. PubMed ID: 16474169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
    Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
    Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.